PharmaMar’s Aplidin In The Spotlight Again As Top EU Court Sets Aside Earlier Ruling On Approval

 
• By Ian Schofield
  
Legal dispute
The EU courts are at odds over a cancer drug from PharmaMar • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography